![CanSino Biologics Inc. logo](/logos/6185.HK.webp)
CanSino Biologics Inc.
HKEX:6185.HK
Overview | Financials
Company Name | CanSino Biologics Inc. |
Symbol | 6185.HK |
Currency | HKD |
Price | 18.58 |
Market Cap | 6,294,898,147 |
Dividend Yield | 0% |
52-week-range | 14.8 - 29.15 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Xuefeng Yu Ph.D. |
Website | https://www.cansinotech.com |
An error occurred while fetching data.
About CanSino Biologics Inc.
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It also develops DTcP vaccine
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD